GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Other Income (Expense)

Vita Life Sciences (ASX:VLS) Other Income (Expense) : A$0.15 Mil (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences Other Income (Expense)?

Vita Life Sciences's other income expense for the Vita Life Sciences's pretax income for the six months ended in Dec. 2023 was A$-0.17 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.15 Mil.

Vita Life Sciences Other Income (Expense) Historical Data

The historical data trend for Vita Life Sciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Other Income (Expense) Chart

Vita Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.59 0.16 -0.08 0.15

Vita Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 0.29 -0.37 0.32 -0.17

Vita Life Sciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vita Life Sciences  (ASX:VLS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Vita Life Sciences (ASX:VLS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Other Income (Expense)
Comparable Companies
ASX:NXS ASX:LV1 ASX:VIT ASX:PER ASX:MVP ASX:IVX ASX:LGP ASX:IDT ASX:ECS ASX:CAN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Website
https://www.vitalifesciences.com
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines